-
Immunic, Inc. (NASDAQ:IMUX) Receives Average Rating of "Buy" from Analysts
ソース: Buzz FX / 04 10 2024 05:03:09 America/New_York
Immunic, Inc. (NASDAQ:IMUX) Receives Average Rating of "Buy" from Analysts Written by MarketBeat October 4, 2024 Share Link copied to clipboard. Immunic, Inc. ( NASDAQ:IMUX - Get Free Report ) has received a consensus recommendation of "Buy
Read more...